Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
More than 2.5 million agricultural workers help maintain America's food supply. They play an important role in the economy, but their work is difficult and often dangerous.
Read Full NewsThe history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.
US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.
Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.
Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.
A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.
Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.
1.
Scientists discover the 'roadmap' that aggressive cancer uses to spread
2.
Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness
3.
Three out of ten breast cancers detected between screenings, study finds
4.
Early Results for Anorexia Nervosa with Psilocybin.
5.
Short-course radiation matches standard therapy for endometrial cancer
1.
Hematopoietic Clonal Competition in Blood Disorders
2.
The Lowdown on Darbepoetin: Understanding Its Uses and Side Effects
3.
The Pros and Cons of Steroid Therapy for ITP
4.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
5.
Hematopoietic Stem Cell Activity Biomarkers in Aging
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
2.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge